Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? (Q51907859)

17 April 2018

title

Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? (English)

1 reference

17 April 2018

1 reference

Giuseppe Vittorio L De Socio

1 reference

17 April 2018

Laura Martinelli

1 reference

17 April 2018

Sabrina Morosi

1 reference

17 April 2018

Maurizio Fiorio

1 reference

17 April 2018

Anna Rita Roscini

1 reference

17 April 2018

Giuliano Stagni

1 reference

17 April 2018

Giuseppe Schillaci

1 reference

17 April 2018

publication date

1 January 2007

1 reference

17 April 2018

published in

Infectious Diseases

1 reference

17 April 2018

volume

1 reference

17 April 2018

issue

1 reference

17 April 2018

page(s)

805-812

1 reference

17 April 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

AIDS — The First 20 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Arterial stiffness and endothelial dysfunction in HIV-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Impact of HIV infection and HAART on serum lipids in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Managing cardiovascular risk in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Metabolic Syndrome Is Associated With Aortic Stiffness in Untreated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

Hypertension in HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701230884

10.1080/00365540701230884

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018